跳至主要内容
临床试验/PACTR201807118984852
PACTR201807118984852已完成未知

Safety And Efficacy Of Adding Intravenous N-Acetyl Cysteine To Parenteral L-Alanyl L-Glutamine In Hospitalized Patients Undergoing Colon Surgeries: A Randomized Controlled Clinical Trial”

ain shams universty0 个研究点目标入组 63 人开始时间: 2018年7月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
63

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients aged between 18 and 80 years.
  • Need for ICU admission after colonic surgery.
  • Requirement of TPN for at least 5 days due to failure of or contraindication for enteral nutrition.
  • Signing a written informed consent

排除标准

  • Patients with persistent hemodynamic instability (systolic blood pressure <80 mm Hg).
  • Renal impairment, hepatic insufficiency.
  • Severe or uncontrolled sepsis
  • Persistent metabolic acidosis.
  • Head trauma, heart failure,
  • Any sensitivity to components of L-alanyl L-glutamine (Dipeptiven®, Fresenius Kabi, Germany) or NAC

研究者

发起方
ain shams universty

相似试验